Nalaganje...
Voriconazole-induced Myositis in a Double Lung Transplant Recipient
Voriconazole is a triazole antifungal agent commercially approved in 2002. It is commonly used in immunocompromised patients as a therapeutic and prophylactic agent. We present the case of a 26-year-old Caucasian female who is a double lung transplant recipient who presented with complaints of gener...
Shranjeno v:
| izdano v: | Cureus |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Cureus
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6445561/ https://ncbi.nlm.nih.gov/pubmed/30989007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3998 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|